Dose quantification |
|
Novel trial designs |
Adaptive trial designs in which pre-planned modifications are made based on interim feasibility data may be more appropriate for investigations of longer-term interventions such as exercise, than traditional dose escalation designs (e.g., “3 + 3”).
The continual reassessment method is an adaptive design that utilizes a model-based approach for phase 1 studies and allows for the consideration of toxicities that may occur late in the observation period.72–74
|
Biological activity |
|
Quality reporting |
Conduct and reporting of clinical trials must adhere to high-level quality standards in order to optimize interpretation, reproducibility, and translation into clinical practice.
In drug development, the implementation of the Consolidated Standards of Reporting Trials (CONSORT) led to marked improvements in RCT rigor, standardization, and conduct.75,76
CONSORT guidance has been extended to non-pharmacologic trials (CONSORT-NPT) to account for behavioral interventions, however current guidelines are suboptimal for exercise trials since they do not provide a standardized mechanism for reporting all exercise prescription components.
Adherence to quality standards can be encouraged by regulatory oversight (not currently mandated for non-pharmacologic trials including exercise).
|
Implementation |
|